{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:54:06Z","timestamp":1765486446814},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer J"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Non-Hodgkin lymphoma encompasses a diverse group of B-cell and T-cell neoplasms. Current classification is based on clinical information, histologic assessment, immunophenotypic characteristics, and molecular alterations. A wide range of genetic alterations, including large chromosomal structural rearrangements, aneuploidies, point mutations, and copy number alterations, have been reported across all types of lymphomas. Many of these are now incorporated into the World Health Organization\u2013defined criteria for the diagnostic evaluation of patients with lymphoid proliferations and, therefore, their accurate identification is paramount for diagnosis, subclassification, and selection of treatment. In addition to their value in the diagnostic setting, many alterations that are not routinely evaluated in standard clinical practice may still define specific disease entities as they have important implications in risk stratification, as well as roles in emerging alternate therapies and disease monitoring. Because of the complexity and range of alterations, their accurate and sensitive assessment requires a careful selection of technology. Here, we discuss the most commonly used molecular techniques in current clinical practice and highlight some of the benefits and pitfalls based on the type of alteration.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000447","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T21:02:18Z","timestamp":1591909338000},"page":"186-194","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Diagnostics of Non-Hodgkin Lymphoma"],"prefix":"10.1097","volume":"26","author":[{"given":"James P.","family":"Solomon","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine New York Presbyterian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Arcila","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230924","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","year":"2016","journal-title":"Blood"},{"key":"bib3-20230924","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"bib4-20230924","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"bib5-20230924","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an international DLBCL rituximab-CHOP consortium program study","volume":"120","year":"2012","journal-title":"Blood"},{"key":"bib6-20230924","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor Ibrutinib","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"bib7-20230924","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/2159-8290.CD-16-1417","article-title":"The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma","volume":"7","year":"2017","journal-title":"Cancer Discov"},{"key":"bib8-20230924","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2016.06.013","article-title":"CBP\/p300 acetyltransferase activity in hematologic malignancies","volume":"119","year":"2016","journal-title":"Mol Genet Metab"},{"key":"bib9-20230924","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","year":"2010","journal-title":"J Mol Diagn"},{"key":"bib10-20230924","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nbt.3423","article-title":"Three decades of nanopore sequencing","volume":"34","year":"2016","journal-title":"Nat Biotechnol"},{"key":"bib11-20230924","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1101\/gr.8.3.186","article-title":"Base-calling of automated sequencer traces using Phred. II. Error probabilities","volume":"8","year":"1998","journal-title":"Genome Res"},{"key":"bib12-20230924","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(81)80068-8","article-title":"New chromosome techniques in the study of human neoplasia","volume":"12","year":"1981","journal-title":"Hum Pathol"},{"key":"bib13-20230924","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ejhg.2015.35","article-title":"Guidelines for cytogenetic investigations in tumours","volume":"24","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"bib14-20230924","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue","volume":"8","year":"2006","journal-title":"J Mol Diagn"},{"key":"bib15-20230924","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajh.24008","article-title":"Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information","volume":"90","year":"2015","journal-title":"Am J Hematol"},{"key":"bib16-20230924","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/2524","article-title":"High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays","volume":"20","year":"1998","journal-title":"Nat Genet"},{"key":"bib17-20230924","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/microarrays4040551","article-title":"SNPs array karyotyping in non-Hodgkin lymphoma","volume":"4","year":"2015","journal-title":"Microarrays (Basel)"},{"key":"bib18-20230924","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1182\/blood-2009-11-203182","article-title":"SNP array analysis in hematologic malignancies: avoiding false discoveries","volume":"115","year":"2010","journal-title":"Blood"},{"key":"bib19-20230924","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2559.2010.03700.x","article-title":"Molecular cytogenetics of lymphoma: where do we stand in 2010?","volume":"58","year":"2011","journal-title":"Histopathology"},{"key":"bib20-20230924","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jmoldx.2016.09.010","article-title":"Next-generation assessment of human epidermal growth factor receptor 2 (ERBB2) amplification status: clinical validation in the context of a hybrid capture\u2013based, comprehensive solid tumor genomic profiling assay","volume":"19","year":"2017","journal-title":"J Mol Diagn"},{"key":"bib21-20230924","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2105-14-S11-S1","article-title":"Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives","volume":"14","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"bib22-20230924","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12859-017-1566-3","article-title":"SeqCNV: a novel method for identification of copy number variations in targeted next-generation sequencing data","volume":"18","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"bib23-20230924","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/nmeth.1374","article-title":"Computational methods for discovering structural variation with next-generation sequencing","volume":"6","year":"2009","journal-title":"Nat Methods"},{"key":"bib24-20230924","first-page":"15.6.1","article-title":"BreakDancer: identification of genomic structural variation from paired-end read mapping","volume":"45","year":"2014","journal-title":"Curr Protoc Bioinformatics"},{"key":"bib25-20230924","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","year":"2009","journal-title":"Bioinformatics"},{"key":"bib26-20230924","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","year":"2012","journal-title":"Bioinformatics"},{"key":"bib27-20230924","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","year":"2019","journal-title":"Clin Cancer Res"},{"key":"bib28-20230924","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1992.tb06463.x","article-title":"Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts","volume":"82","year":"1992","journal-title":"Br J Haematol"},{"key":"bib29-20230924","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","year":"2020","journal-title":"Mod Pathol"},{"key":"bib30-20230924","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1002\/j.1460-2075.1995.tb00311.x","article-title":"Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma","volume":"14","year":"1995","journal-title":"EMBO J"},{"key":"bib31-20230924","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","year":"2014","journal-title":"Nat Med"},{"key":"bib32-20230924","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.2017.35.7_suppl.72","article-title":"Clinical utility of clonality testing by next generation sequencing in the monitoring of B-cell and T-cell malignancies","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"key":"bib33-20230924","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/2040620713519729","article-title":"The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies","volume":"5","year":"2014","journal-title":"Ther Adv Hematol"},{"key":"bib34-20230924","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","year":"2003","journal-title":"Leukemia"},{"key":"bib35-20230924","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jmoldx.2018.10.008","article-title":"Establishment of immunoglobulin heavy (IGH) chain clonality testing by next-generation sequencing for routine characterization of B-cell and plasma cell neoplasms","volume":"21","year":"2019","journal-title":"J Mol Diagn"},{"key":"bib36-20230924","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1021\/bi060307w","article-title":"Thermodynamic, counterion, and hydration effects for the incorporation of locked nucleic acid nucleotides into DNA duplexes","volume":"45","year":"2006","journal-title":"Biochemistry"},{"key":"bib37-20230924","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1021\/bi200904e","article-title":"Stability and mismatch discrimination of locked nucleic acid-DNA duplexes","volume":"50","year":"2011","journal-title":"Biochemistry"},{"key":"bib38-20230924","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jbiotec.2017.07.026","article-title":"Peptide nucleic acids: advanced tools for biomedical applications","volume":"259","year":"2017","journal-title":"J Biotechnol"},{"key":"bib39-20230924","first-page":"42","article-title":"Discrimination among the human beta a, beta S, and beta C-globin genes using allele-specific oligonucleotide hybridization probes","volume":"37","year":"1985","journal-title":"Am J Hum Genet"},{"key":"bib40-20230924","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11899-018-0468-4","article-title":"Updates on circulating tumor DNA assessment in lymphoma","volume":"13","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"bib41-20230924","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14737159.2017.1319765","article-title":"The value of liquid biopsy in diagnosis and monitoring of diffuse large B-cell lymphoma: recent developments and future potential","volume":"17","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"suppl 1","key":"bib42-20230924","first-page":"70","article-title":"Liquid biopsy in non-Hodgkin's lymphoma","volume":"37","year":"2019","journal-title":"Hematol Oncol"},{"key":"bib43-20230924","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jmoldx.2015.05.007","article-title":"Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma: a comparison with real-time PCR","volume":"17","year":"2015","journal-title":"J Mol Diagn"},{"key":"bib44-20230924","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","article-title":"Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort","volume":"8","year":"2018","journal-title":"Blood Cancer J"},{"key":"bib45-20230924","first-page":"72","article-title":"Counting absolute numbers of molecules using unique molecular identifiers","volume":"9","year":"2011","journal-title":"Nat Methods"},{"key":"bib46-20230924","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gr.209601.116","article-title":"UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy","volume":"27","year":"2017","journal-title":"Genome Res"},{"key":"bib47-20230924","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3324\/haematol.2018.206177","article-title":"Liquid biopsy in lymphoma","volume":"104","year":"2019","journal-title":"Haematologica"},{"key":"bib48-20230924","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","year":"2014","journal-title":"Nat Med"},{"key":"bib49-20230924","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","year":"2000","journal-title":"Nature"},{"key":"bib50-20230924","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","year":"2004","journal-title":"Blood"},{"key":"bib51-20230924","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","year":"2009","journal-title":"Clin Cancer Res"},{"key":"bib52-20230924","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"bib53-20230924","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","year":"2018","journal-title":"Nat Med"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T05:26:34Z","timestamp":1695533194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000447","relation":{},"ISSN":["1540-336X","1528-9117"],"issn-type":[{"value":"1540-336X","type":"electronic"},{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}